Feedback / Questions
ARZC-001 - Artizan Biosci
https://www.globenewswire.com/news-release/2022/01/18/2368317/0/en/Artizan-Biosciences-Selects-Lead-Product-Candidate-for-Inflammatory-Bowel-Disease-Therapeutic-Development-Program.html
Jan 18, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious